MHRA approves Amgen’s Lumykras under Project Orbis
Project Orbis is an international collaborative programme between the FDA and worldwide regulatory agencies
Read More
Tag: Lumykras
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
- Fabentech secures French approval for Ricimed antidote
